1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
6. Choi IJ, Lee JH, Kim YI, et al. Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointest Endosc 2015 81:333–341; e1.
9. Schistosomes, liver flukes and
Helicobacter pylori. In: IARC Working Group on the evaluation of carcinogenic risks to humans; Lyon. 7-14 June 1994; IARC Monogr Eval Carcinog Risks Hum 1994;61:pp 1–241.
10. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554–3560.
11. Wong BC, Lam SK, Wong WM, et al.
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187–194.
12. Chen HN, Wang Z, Li X, Zhou ZG.
Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer 2016;19:166–175.
13. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Early
Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009 137:1641–1648; e1-e2.
14. Choi IJ, Kook MC, Kim YI, et al.
Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018;378:1085–1095.
15. Hwang YJ, Kim N, Lee HS, et al. Reversibility of atrophic gastritis and intestinal metaplasia after
Helicobacter pylori eradication - a prospective study for up to 10 years. Aliment Pharmacol Ther 2018;47:380–390.
16. Choi JM, Kim SG, Choi J, et al. Effects of
Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial. Gastrointest Endosc 2018 88:475–485; e2.
17. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of
Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392–397.
18. Yoon SB, Park JM, Lim CH, Cho YK, Choi MG. Effect of
Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter 2014;19:243–248.
19. Zhao B, Zhang J, Mei D, et al. Does Helicobacter pylori eradication reduce the incidence of metachronous gastric cancer after curative endoscopic resection of early gastric cancer: a systematic review and meta-analysis J Clin Gastroenterol; 2019 doi: 10.1097/MCG.0000000000001195. [Epub ahead of print].
20. Xiao S, Li S, Zhou L, Jiang W, Liu J.
Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis. J Gastroenterol 2019;54:226–237.
21. Uemura N, Mukai T, Okamoto S, et al. Effect of
Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639–642.
22. Choi J, Kim SG, Yoon H, et al. Eradication of
Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol 2014 12:793–800; e1.
23. Gyawali B, Kesselheim AS, D'Andrea E. Does
Helicobacter pylori eradication therapy to prevent gastric cancer increase all-cause mortality? Int J Cancer 2019;144:411–412.
25. Winkel P, Hilden J, Hansen JF, et al. Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial. Int J Cardiol 2015;182:459–465.
26. Shiraev TP, Bullen A. Proton pump inhibitors and cardiovascular events: a systematic review. Heart Lung Circ 2018;27:443–450.
27. Kim YI, Kim YA, Lee JW, et al. Effect of Helicobacter pylori treatment on long-term mortality in patients with hypertension Gut Liver; 2019 doi: 10.5009/gnl18510. [Epub ahead of print].
28. Takagi T, Naito Y, Inoue R, et al. The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study. J Clin Biochem Nutr 2018;62:100–105.
31. van der Hulst RW, van der Ende A, Dekker FW, et al. Effect of
Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997;113:25–30.
32. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of
Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007;12 Suppl 2:32–38.
33. Wang J, Xu L, Shi R, et al. Gastric atrophy and intestinal metaplasia before and after
Helicobacter pylori eradication: a meta-analysis. Digestion 2011;83:253–260.
34. Kong YJ, Yi HG, Dai JC, Wei MX. Histological changes of gastric mucosa after
Helicobacter pylori eradication: a systematic review and meta-analysis. World J Gastroenterol 2014;20:5903–5911.